ICMH
PEARW

Integrity Capital Management (HK)’s Pear Therapeutics, Inc. Warrant PEARW Stock Holding History

Integrity Capital Management (HK)’s Portfolio PEARW Stock Details PEARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-50,333
Closed -$30K – 299
2021
Q4 		$30K Buy
+50,333
New +$51.1K 0.1% 236

Other funds holding PEARW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
KCM
Kingstown Capital Management New York $30.4M AUM 3.71% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Integrity Capital Management (HK)'s PEARW Position: Q1 2022 in Review

Integrity Capital Management (HK) sold out of Pear Therapeutics, Inc. Warrant (PEARW) in Q1 2022, closing a stake of 50,333 shares — an estimated $30K sold.

Integrity Capital Management (HK) first reported a position in PEARW in Q4 2021 and held it in 1 quarter. The position peaked at $30K in Q4 2021. 40 funds tracked by Wall St. Rank hold PEARW as of Q1 2022.

  • Integrity Capital Management (HK) reported no remaining Pear Therapeutics, Inc. Warrant position as of Q1 2022 after selling out during the quarter.
  • Integrity Capital Management (HK) sold 50,333 Pear Therapeutics, Inc. Warrant shares in Q1 2022, an estimated $30K.
  • Integrity Capital Management (HK) first reported a position in Pear Therapeutics, Inc. Warrant in Q4 2021 and held it in 1 quarter.
  • Integrity Capital Management (HK)'s Pear Therapeutics, Inc. Warrant position peaked at $30K in Q4 2021.
  • 40 funds tracked by Wall St. Rank held Pear Therapeutics, Inc. Warrant as of Q1 2022.

Based on Integrity Capital Management (HK)'s 13F filing for Q1 2022, filed 26 Apr 2022.